Jurczak, W. Et Al. 2023. Dose-Escalation, Dose-Confirmation, and CohortExpansion Study of Nemtabrutinib in Patients With Hematologic Malignancies: Multicohort, Open label, Phase 2BELLWAVE-003Study. AMERICAN JOURNAL OF HEMATOLOGY .

Jurczak, W., Perini, G. F., Owen, C., ÖZCAN, M., Gonzalez Barca, E., Wrobel, T., ... Lavie, D.(2023). Dose-Escalation, Dose-Confirmation, and CohortExpansion Study of Nemtabrutinib in Patients With Hematologic Malignancies: Multicohort, Open label, Phase 2BELLWAVE-003Study. AMERICAN JOURNAL OF HEMATOLOGY .

Jurczak, Wojciech Et Al. "Dose-Escalation, Dose-Confirmation, and CohortExpansion Study of Nemtabrutinib in Patients With Hematologic Malignancies: Multicohort, Open label, Phase 2BELLWAVE-003Study," AMERICAN JOURNAL OF HEMATOLOGY , 2023

Jurczak, Wojciech Et Al. "Dose-Escalation, Dose-Confirmation, and CohortExpansion Study of Nemtabrutinib in Patients With Hematologic Malignancies: Multicohort, Open label, Phase 2BELLWAVE-003Study." AMERICAN JOURNAL OF HEMATOLOGY , 2023

Jurczak, W. Et Al. (2023) . "Dose-Escalation, Dose-Confirmation, and CohortExpansion Study of Nemtabrutinib in Patients With Hematologic Malignancies: Multicohort, Open label, Phase 2BELLWAVE-003Study." AMERICAN JOURNAL OF HEMATOLOGY .

@article{article, author={Wojciech Jurczak Et Al. }, title={Dose-Escalation, Dose-Confirmation, and CohortExpansion Study of Nemtabrutinib in Patients With Hematologic Malignancies: Multicohort, Open label, Phase 2BELLWAVE-003Study}, journal={AMERICAN JOURNAL OF HEMATOLOGY}, year=2023}